Skip to main content
. 2018 Oct 9;8:15028. doi: 10.1038/s41598-018-33408-9

Table 3.

CRISPR/Zygote Approach Microinjection Results.

Experiment Number Donor Vector (ng/µL) Guide Set Zygotes Injected/Transferred Newborns Liveborna Stillbornb Lost Before Weanc Weanedd Founderse
1 and 6 combined 5 OPTIMAL POSITION (G5-G8) 147 33 22.4% 30 90.9% 3 9.1% 1 3.3%% 29 96.7% 1f 3.4%
2 1 OPTIMAL POSITION (G5-G8) 75 8 10.7% 8 100.0% 0 0.0% 0 0.0% 8 100.0% 1g 12.5%
4 1 OPTIMAL SCORE (G1-G4) 81 17 21.0% 17 100.0% 0 0.0% 1 5.9% 16 94.1% 0 0.0%
7 10 OPTIMAL SCORE (G1-G4) 69 8 11.6% 7 87.5% 1 12.5% 0 0.0% 7 100.0% 1g 14.3%
8 5 OPTIMAL SCORE (G1-G4) 76 23 30.3% 22 95.7% 1 4.3% 1 4.5% 21 95.5% 0 0.0%
Totals 448 89 19.9% 84 94.4% 5 5.6% 3 3.6% 81 96.4% 3 3.7%

Mice recovered from the CRISPR/Zygote Approach microinjection experiments (described in Table 2) are shown. These experiments tested permutations of two design parameters — targeting vector/donor DNA concentration (at 1, or 5, or 10 ng/µL) and sgRNA design (optimal score or optimal position). Experiments 1 and 6 are replicates; the results of these experiments are combined. Experiments 3 and 5 were technical failures resulting in no wean-age mice (see Supplementary Table 4 for details). Experiments 2, 6, and 7 generated single founder animals. See Table 4 for details.

aPercentage calculated as Liveborn/Newborns × 100.

bPercentage calculated as Stillborn/Newborns × 100.

cPercentage calculated as Lost Before Wean/Liveborn × 100.

dPercentage calculated as Weaned/Liveborn × 100.

ePercentage calculated as Founders/Weaned × 100.

fProper integration and transmission confirmed. See Tables 4, 5, and text for details.

gWas not transmitted through the germline. See Tables 4, 5, and text for details.